Showing 406 to 420 of 2052 results
Fitness to practise annual report 2017
This report provides information about the HCPC’s work in considering allegations about the fitness to practise of HCPC registrants.
Freedom of Information Policy
The Freedom of Information Act 2000 (FOIA) enables anyone to request recorded information held by the Health and Care Professions Council (HCPC)
Protected function - hearing aid dispensers
We regulate hearing aid dispensers on the basis of their professional title and also their protected function.
Review of the standards of education and training
We are undertaking a review of the standards of education and training (SETs).
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
HCPC response to consultation on patient group directions for ODPs
Health and Care Professions Council response to NHS England’s consultation on the proposal for the supply and administration of medicines using patient group directions for operating department practitioners across the United Kingdom
Before we begin
The first page you’ll see is the ‘Before we begin’ page
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
Assessing SET1 - Threshold level of qualification
This policy statement sets out our broad approach to assessing the threshold level of qualification for entry to the Register.
Professional bodies for occupational therapists
Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.
A review of our education outcomes for the academic year
We have looked back on our approval and monitoring outcomes from the last academic year
HCPC Corporate Plan 2025-26
The HCPC Corporate Plan 2025-26 sets out how we will continue to make progress on each of our six strategic priorities over the year.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)